This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Advance Live Sessions Jan 5Tuesday, 5 January 2021 - PST/PDT (Pacific Daylight, GMT-7)

Session content is available on-demand in partneringONE until March 31

Tuesday, 5 January 2021 8:30am - 9:00am30 mins

January 5 LIVE

In conversation with the COVID-19 leaders: A sense of urgency and collaboration

Paul Colvin - President, Clinical Solutions, Syneos Health
Kumar Srinivasan - VP and Global Head of Business Development and Licensing, BioPharmaceuticals R&D, AstraZeneca Pharmaceuticals

Tuesday, 5 January 2021 10:00am - 10:45am45 mins

January 5 LIVE

Part 1 - The world according to COVID-19: From crisis to long-term impact

Leah Rosenbaum - Assistant Editor, Healthcare & Science, Forbes
Jeremy Levin - CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)
Michelle McMurry-Heath - President and CEO, Biotechnology Innovation Organization (BIO)

Tuesday, 5 January 2021 10:45am - 11:15am30 mins

January 5 LIVE

Part 2 - The world according to COVID-19: Inside Operation Warp Speed

Michelle McMurry-Heath - President and CEO, Biotechnology Innovation Organization (BIO)
Jeremy Levin - CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)
Moncef Slaoui - Scientific Head, Operation Warp Speed